In February this year, EILF kicked off Phase 1 of the EILF NAFLD Policy Review. This first of its kind research project aims to establish to what extent governments and key stakeholders like medical associations and patient groups are responding to the major public health threat that is non-alcoholic fatty liver disease (NAFLD)/ non-alcoholic steatohepatitis (NASH), raise awareness of the conditions and inform on the need for further initiatives and areas for collaboration. Phase 1 saw the review completed in 8 countries and the preliminary results showcased in a briefing chaired by Prof. Jeffrey Lazarus, and Prof. Quentin Anstee at the EASL International Liver Congress in April. Whilst the results are being written up for publication, Phase 2 will launch, seeing the review expanded to the remaining EU-28 countries.